Teru Kawasoe

1.6k total citations · 1 hit paper
18 papers, 1.3k citations indexed

About

Teru Kawasoe is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Teru Kawasoe has authored 18 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Teru Kawasoe's work include Breast Cancer Treatment Studies (4 papers), Cancer-related gene regulation (4 papers) and Cancer Treatment and Pharmacology (3 papers). Teru Kawasoe is often cited by papers focused on Breast Cancer Treatment Studies (4 papers), Cancer-related gene regulation (4 papers) and Cancer Treatment and Pharmacology (3 papers). Teru Kawasoe collaborates with scholars based in Japan, United Kingdom and China. Teru Kawasoe's co-authors include Tadashi Nishiwaki, Yataro Daigo, Yoichi Furukawa, Hideyuki Ishiguro, Yusuke Nakamura, Manabu Fujita, Seiji Satoh, Nobutomo Miwa, Hirotaka Iwase and Takashi Tokino and has published in prestigious journals such as Nature Genetics, Journal of Clinical Oncology and Clinical Cancer Research.

In The Last Decade

Teru Kawasoe

18 papers receiving 1.3k citations

Hit Papers

AXIN1 mutations in hepatocellular carcinomas, and growth ... 2000 2026 2008 2017 2000 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Teru Kawasoe Japan 11 953 332 292 183 96 18 1.3k
Tadashi Nishiwaki Japan 8 1.1k 1.1× 322 1.0× 136 0.5× 134 0.7× 98 1.0× 11 1.3k
Tetsuhiro Goto Japan 20 698 0.7× 368 1.1× 251 0.9× 219 1.2× 53 0.6× 47 1.1k
Kandavel Shanmugam United States 13 629 0.7× 509 1.5× 179 0.6× 195 1.1× 94 1.0× 27 1.1k
Hiroki Mizukami Japan 20 646 0.7× 361 1.1× 226 0.8× 188 1.0× 50 0.5× 47 1.0k
Mary K. Washington United States 6 595 0.6× 480 1.4× 179 0.6× 114 0.6× 85 0.9× 10 996
Yongping Crawford United States 14 1.1k 1.2× 581 1.8× 450 1.5× 75 0.4× 100 1.0× 16 1.5k
A. Reza Radjabi United States 8 793 0.8× 287 0.9× 569 1.9× 86 0.5× 76 0.8× 9 1.3k
Ian A.J. Lorimer Canada 21 710 0.7× 518 1.6× 399 1.4× 132 0.7× 102 1.1× 41 1.3k
Alice Faversani Italy 15 644 0.7× 262 0.8× 419 1.4× 74 0.4× 96 1.0× 20 1.0k
Jane D. Holland Germany 10 879 0.9× 569 1.7× 244 0.8× 63 0.3× 100 1.0× 11 1.3k

Countries citing papers authored by Teru Kawasoe

Since Specialization
Citations

This map shows the geographic impact of Teru Kawasoe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Teru Kawasoe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Teru Kawasoe more than expected).

Fields of papers citing papers by Teru Kawasoe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Teru Kawasoe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Teru Kawasoe. The network helps show where Teru Kawasoe may publish in the future.

Co-authorship network of co-authors of Teru Kawasoe

This figure shows the co-authorship network connecting the top 25 collaborators of Teru Kawasoe. A scholar is included among the top collaborators of Teru Kawasoe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Teru Kawasoe. Teru Kawasoe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
2.
Narui, Kazutaka, Toshinari Yamashita, Masahiro Kitada, et al.. (2017). Eribulin in combination with pertuzumab plus trastuzumab for HER2-positive advanced or recurrent breast cancer (JBCRG-M03).. Journal of Clinical Oncology. 35(15_suppl). 1025–1025. 1 indexed citations
3.
Hayashi, Mitsuhiro, Yutaka Yamamoto, Aiko Sueta, et al.. (2015). Associations Between Elastography Findings and Clinicopathological Factors in Breast Cancer. Medicine. 94(50). e2290–e2290. 16 indexed citations
4.
Zhang, Zhenhuan, Hiroko Yamashita, Tatsuya Toyama, et al.. (2009). Nuclear corepressor 1 expression predicts response to first-line endocrine therapy for breast cancer patients on relapse.. PubMed. 122(15). 1764–8. 10 indexed citations
5.
Yamamoto, Yutaka, et al.. (2009). Clinical significance of basal-like subtype in triple-negative breast cancer. Breast Cancer. 16(4). 260–267. 55 indexed citations
6.
Nakano, Masahiro, Yutaka Yamamoto, Teru Kawasoe, et al.. (2009). [A case of spindle cell carcinoma of the breast including metaplastic lesion with poor prognosis].. PubMed. 36(6). 1017–9. 1 indexed citations
7.
Ibusuki, Mutsuko, Yutaka Yamamoto, Teru Kawasoe, et al.. (2009). Potential advantage of preoperative three-dimensional mapping of sentinel nodes in breast cancer by a hybrid single photon emission CT (SPECT)/CT system. Surgical Oncology. 19(2). 88–94. 21 indexed citations
8.
Iwase, Hirotaka, Yutaka Yamamoto, Teru Kawasoe, & Mutsuko Ibusuki. (2009). Advantage of sentinel lymph node biopsy before neoadjuvant chemotherapy in breast cancer treatment. Surgery Today. 39(5). 374–380. 18 indexed citations
9.
Okumura, Yasuhiro, Yutaka Yamamoto, Zhenhuan Zhang, et al.. (2008). Identification of biomarkers in ductal carcinoma in situ of the breast with microinvasion. BMC Cancer. 8(1). 287–287. 31 indexed citations
10.
Yamamoto, Yutaka, Mutsuko Ibusuki, Yasuhiro Okumura, et al.. (2007). Hypoxia-inducible factor 1α is closely linked to an aggressive phenotype in breast cancer. Breast Cancer Research and Treatment. 110(3). 465–475. 126 indexed citations
11.
Zhang, Zhenhuan, Hiroko Yamashita, Tatsuya Toyama, et al.. (2006). Reduced Expression of theBreast Cancer Metastasis Suppressor 1mRNA Is Correlated with Poor Progress in Breast Cancer. Clinical Cancer Research. 12(21). 6410–6414. 54 indexed citations
12.
Kawasoe, Teru, Yutaka Yamamoto, Yasuhiro Okumura, & Hirotaka Iwase. (2006). A case report of paraneoplastic neurological syndrome associated with occuft breast cancer. Breast Cancer. 13(2). 202–204. 7 indexed citations
13.
Furukawa, Yoichi, Teru Kawasoe, Yataro Daigo, et al.. (2001). Isolation of a Novel Human Gene, ARHGAP9, Encoding a Rho-GTPase Activating Protein. Biochemical and Biophysical Research Communications. 284(3). 643–649. 52 indexed citations
14.
Ishiguro, Hideyuki, Yoichi Furukawa, Yataro Daigo, et al.. (2000). Isolation and Characterization of Human NBL4, a Gene Involved in the β‐Catenin/Tcf Signaling Pathway. Japanese Journal of Cancer Research. 91(6). 597–603. 34 indexed citations
15.
Nishiwaki, Tadashi, Yataro Daigo, Teru Kawasoe, & Yusuke Nakamura. (2000). Isolation and mutational analysis of a novel human cDNA, DEC1 (deleted in esophageal cancer 1), derived from the tumor suppressor locus in 9q32. Genes Chromosomes and Cancer. 27(2). 169–176. 4 indexed citations
16.
Satoh, Seiji, Yataro Daigo, Yoichi Furukawa, et al.. (2000). AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1. Nature Genetics. 24(3). 245–250. 792 indexed citations breakdown →
17.
Nishiwaki, Tadashi, Yataro Daigo, Teru Kawasoe, & Yusuke Nakamura. (2000). Isolation and mutational analysis of a novel human cDNA,DEC1 (deleted in esophageal cancer 1), derived from the tumor suppressor locus in 9q32. Genes Chromosomes and Cancer. 27(2). 169–176. 37 indexed citations
18.
Nishiwaki, Tadashi, Yataro Daigo, Teru Kawasoe, et al.. (1999). Isolation and characterization of a human cDNA homologous to the Xenopus laevis XCAP-C gene belonging to the structural maintenance of chromosomes (SMC) family. Journal of Human Genetics. 44(3). 197–202. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026